marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Lexicon Pharmaceuticals Financial Ratios 2011-2024 | LXRX
Annual Financial Ratios Lexicon Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-2.6 | -4.5 | -6.5 | - | 2.6 | -3.9 | -9.0 | -10.0 | -225.5 | -4.8 | -9.0 | -9.4 | -4.4 |
P/S |
389.4 | 3278.9 | 1925.7 | - | 1.1 | 7.4 | 12.9 | 17.0 | 8.1 | 21.3 | 422.6 | 948.8 | 274.6 |
EPS |
-0.8 | -0.6 | -0.6 | -0.5 | 1.2 | -1.1 | -1.2 | -1.4 | -0.1 | -0.2 | -0.2 | -0.2 | -0.3 |
EV (Enterprise Value) |
583 M | 487 M | 533 M | -78.8 M | 604 M | 697 M | 1.48 B | 1.69 B | 1.22 B | 536 M | 1.01 B | 1.11 B | 454 M |
EBITDA per Share |
-0.77 | -0.61 | -0.6 | - | 1.64 | -0.941 | -1.25 | -1.31 | 0.113 | -1.1 | -1.39 | -1.35 | -2.24 |
EV/EBITDA |
0.5 | -4.4 | 3.2 | -6.3 | -10.3 | -10.9 | 81.8 | -5.4 | -9.1 | -10.9 | -3.2 | ||
PEG |
- | 0.1 | 0.01 | -0.53 | -0.94 | 0.0 | -2.34 | -0.97 | -0.69 | -0.29 | -1.63 | ||
P/B |
5.0 | 3.9 | 5.1 | - | 2.9 | -17.7 | 22.3 | 9.0 | 3.7 | 1.7 | 5.5 | 3.9 | 1.7 |
P/CF |
-2.9 | -5.1 | -6.6 | - | 3.0 | -3.1 | -6.3 | -8.1 | 5.7 | -6.4 | -10.1 | -10.9 | -5.7 |
ROE % |
-190.23 | -87.04 | -77.26 | -37.46 | 111.13 | 456.53 | -247.69 | -89.85 | -1.64 | -35.31 | -61.19 | -41.33 | -39.05 |
ROA % |
-77.20 | -52.47 | -64.10 | -28.74 | 31.15 | -42.43 | -29.56 | -29.74 | -0.71 | -21.28 | -37.98 | -29.64 | -26.99 |
ROCE % |
-184.46 | -86.03 | -76.67 | -30.57 | 48.27 | -41.75 | -43.08 | -44.33 | 2.07 | -20.13 | -41.03 | -27.87 | -27.89 |
Current Ratio |
1.7 | 2.5 | 5.9 | 4.3 | 5.2 | 4.7 | 2.6 | 2.2 | 4.3 | 8.2 | 7.0 | 12.6 | 13.4 |
DSO |
157.3 | 55.1 | 250.5 | 433.0 | 64.1 | 34.2 | 19.5 | 32.8 | 2.6 | 16.5 | 129.8 | 461.9 | 69.1 |
DIO |
818.0 | - | - | 401.4 | 479.3 | 685.7 | 374.4 | - | - | - | - | - | - |
DPO |
53212.7 | - | - | 1669.6 | 1375.7 | 2602.2 | 11081.1 | - | - | - | - | - | - |
Operating Cycle |
975.4 | 55.1 | 250.5 | 834.4 | 543.4 | 720.0 | 393.9 | - | - | - | - | - | - |
Cash Conversion Cycle |
-52237.3 | 55.1 | 250.5 | -835.2 | -832.3 | -1882.2 | -10687.2 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Lexicon Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.18 | -0.17 | -0.2 | -0.21 | -0.22 | -0.17 | - | -0.13 | -0.16 | -0.16 | - | -0.16 | -0.13 | -0.15 | - | 0.77 | -0.65 | -0.63 | -0.48 | 2.13 | -0.22 | -0.42 | -0.16 | -0.26 | -0.33 | -0.4 | -0.25 | -0.29 | -0.33 | -0.33 | -0.31 | -0.35 | -0.37 | -0.34 | 0.84 | -0.34 | -0.27 | -0.27 | -0.03 | -0.55 | -0.35 | -0.06 | -0.03 | -0.06 | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 | -0.06 | -0.1 | -0.08 | -0.08 | -0.09 |
EBITDA per Share |
- | - | -0.18 | - | - | -0.16 | - | -0.13 | -0.16 | -0.16 | - | -0.16 | -0.12 | -0.15 | - | 0.83 | -0.59 | -0.58 | - | 2.14 | -0.17 | -0.32 | -0.12 | -0.19 | -0.27 | -0.35 | -0.27 | -0.25 | -0.3 | -0.37 | -0.3 | -0.32 | -0.35 | -0.32 | 0.85 | -0.32 | -0.25 | -0.25 | -0.04 | -0.53 | -0.34 | -0.06 | -0.03 | -0.06 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.06 | -0.1 | -0.06 | -0.07 | -0.08 |
ROE % |
-111.54 | -99.33 | -113.33 | -112.82 | -92.84 | -103.46 | -76.28 | -93.20 | -93.89 | -72.34 | -43.83 | 8.99 | 78.75 | 47.74 | -33.94 | -77.61 | 62.63 | 142.28 | 146.60 | 253.83 | 164.51 | 259.88 | 456.53 | 354.00 | 193.03 | -4.33 | -223.97 | -204.34 | -170.01 | -127.71 | -88.61 | -38.92 | -28.38 | -13.99 | -1.65 | -33.02 | -34.93 | -34.28 | -35.31 | -44.51 | -48.86 | -56.78 | -61.19 | -60.29 | -52.76 | -45.39 | -41.33 | -43.37 | -41.07 | -40.30 | -39.05 | -8.77 | -8.95 | -9.96 |
ROA % |
-64.37 | -58.36 | -63.68 | -64.28 | -58.20 | -61.27 | -46.68 | -60.10 | -44.07 | -54.60 | -34.79 | 5.75 | 59.70 | 36.33 | -26.05 | -38.29 | -24.70 | -0.68 | 21.28 | 27.62 | -36.15 | -38.44 | -42.43 | -42.62 | -39.80 | -35.58 | -28.17 | -28.90 | -29.64 | -29.71 | -29.74 | -9.61 | -7.45 | -3.75 | -0.72 | -14.65 | -17.83 | -19.04 | -21.28 | -27.01 | -29.96 | -35.05 | -37.98 | -38.32 | -34.72 | -31.08 | -29.64 | -30.82 | -28.93 | -28.15 | -26.99 | -6.06 | -6.19 | -6.88 |
ROCE % |
-110.01 | -98.07 | -110.38 | -110.72 | -91.18 | -101.34 | -75.15 | -91.96 | -92.73 | -71.93 | -43.56 | 11.87 | 84.11 | 55.90 | -25.80 | -66.12 | 70.32 | 140.20 | 149.37 | 236.53 | 131.49 | 217.55 | 391.13 | 301.79 | 160.06 | -18.86 | -237.52 | -213.72 | -181.01 | -140.25 | -85.94 | -36.33 | -25.92 | -11.74 | 0.50 | -31.61 | -34.03 | -33.89 | -35.34 | -44.10 | -48.24 | -55.87 | -60.16 | -59.37 | -51.92 | -44.65 | -40.65 | -42.67 | -40.41 | -39.57 | -38.34 | -8.63 | -8.71 | -9.79 |
Current Ratio |
2.2 | 2.8 | 3.2 | 2.0 | 2.4 | 2.2 | 2.5 | 4.0 | - | 3.1 | 5.9 | 4.8 | 5.0 | 4.8 | 4.3 | 4.3 | 4.3 | 4.3 | 1.4 | 1.4 | 0.8 | 1.4 | 0.9 | 0.9 | 0.9 | 0.9 | 1.2 | 1.1 | 1.1 | 1.1 | 1.5 | 1.5 | 1.5 | 1.5 | 1.8 | 1.8 | 1.8 | 1.8 | 2.5 | 2.5 | 2.5 | 2.5 | 2.6 | 2.6 | 2.6 | 2.6 | 3.5 | 3.5 | 3.5 | 3.5 | 3.2 | 3.2 | 3.2 | 3.2 |
DSO |
143.8 | 114.8 | 74.5 | 282.5 | 136.2 | 549.4 | - | 45.6 | 48.2 | - | - | 361.0 | 50.7 | 838.1 | - | 5.4 | 3.9 | 324.7 | 591.1 | 9.6 | 292.7 | 150.8 | 31.7 | 77.6 | 39.2 | 19.3 | 13.3 | 16.3 | 36.5 | 30.7 | 29.7 | 24.7 | 34.0 | 30.7 | 0.7 | 146.9 | 221.1 | 49.5 | 4.4 | 225.4 | 139.7 | 300.6 | 51.1 | 302.9 | 336.9 | 274.8 | 576.8 | 338.0 | 631.9 | 262.8 | 93.1 | 90.0 | 57.5 | - |
DIO |
784.6 | 302.1 | 1251.0 | 3311.1 | - | - | - | - | - | - | - | - | - | - | - | 287.5 | 509.9 | 673.9 | - | 673.7 | 292.9 | 216.6 | - | 775.0 | 509.6 | 567.4 | - | 296.8 | 331.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
16978.3 | 5575.9 | 29587.1 | 146893.0 | 118693.4 | - | - | - | - | - | - | - | - | - | - | 788.4 | 685.5 | 1417.5 | - | 1755.9 | 763.5 | 588.0 | - | 2941.0 | 1933.8 | 4838.2 | - | 8782.5 | 9796.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
928.4 | 416.9 | 1325.5 | 3593.6 | 136.2 | 549.4 | - | 45.6 | 48.2 | - | - | 361.0 | 50.7 | 838.1 | - | 292.9 | 513.8 | 998.6 | 591.1 | 683.3 | 585.6 | 367.3 | 31.7 | 852.6 | 548.8 | 586.7 | 13.3 | 313.1 | 367.5 | 30.7 | 29.7 | 24.7 | 34.0 | 30.7 | 0.7 | 146.9 | 221.1 | 49.5 | 4.4 | 225.4 | 139.7 | 300.6 | 51.1 | 302.9 | 336.9 | 274.8 | 576.8 | 338.0 | 631.9 | 262.8 | 93.1 | 90.0 | 57.5 | - |
Cash Conversion Cycle |
-16049.9 | -5159.0 | -28261.6 | -143299.4 | -118557.3 | 549.4 | - | 45.6 | 48.2 | - | - | 361.0 | 50.7 | 838.1 | - | -495.4 | -171.7 | -418.9 | 591.1 | -1072.6 | -177.9 | -220.7 | 31.7 | -2088.4 | -1385.0 | -4251.5 | 13.3 | -8469.5 | -9429.0 | 30.7 | 29.7 | 24.7 | 34.0 | 30.7 | 0.7 | 146.9 | 221.1 | 49.5 | 4.4 | 225.4 | 139.7 | 300.6 | 51.1 | 302.9 | 336.9 | 274.8 | 576.8 | 338.0 | 631.9 | 262.8 | 93.1 | 90.0 | 57.5 | - |
All numbers in USD currency